ADVANCING WOMEN’S RIGHT TO HEALTHUnmet needs in women’s health still undermine their universal right to health and require urgent and concrete action. This was brought into sharp focus last month during International Women’s Day, under the theme “Rights. Justice. Action.” Too often, women’s health needs are overlooked. Differences in how health conditions affect women are not consistently reflected in research, diagnosis or care. Medical systems have long been shaped around male-centric data and assumptions, leaving critical gaps in understanding and supporting women’s health. These gaps For example, women living with diabetes face challenges linked to both biological and social factors. Hormonal changes across the life course, from puberty and menstruation to pregnancy and menopause, can significantly affect blood glucose patterns, insulin sensitivity and treatment responses, making diabetes management more complex. In addition, gender-related aspects – including caregiving responsibilities, socio-economic inequalities and differences in how symptoms are recognised and acted upon, including a greater likelihood of their being overlooked or misattributed – can have a further impact on access to timely diagnosis and care. Yet clinical protocols, care delivery and
Closing the sex- and gender gap requires more than awareness; it demands targeted policy action. A key opportunity for progress lies in the Among the voices driving this change is MEP Sirpa Pietikäinen, Member of the MEPs Mobilising for Diabetes Interest Group (MMD) and shadow rapporteur for the SANT opinion on the FEMM report, who emphasises:
MEP Sirpa Pietikäinen ![]() IDF EUROPE, NEWS, ACTIVITIES AND EVENTSIDF Europe TEAM Meeting and Regional Council 2026 On March 27–28, we held our TEAM Meeting (Together Everyone Achieves More) bringing together member associations, partners and representatives from other health organisations. Key sessions explored the national implementation of the EU Safe Hearts Plan, the use of AI in association management, the potential and safety of continuous glucose monitors (CGMs) and existing and potential collaborations across chronic disease communities. The programme featured award lectures from the co-winners of the IDF Europe Advocate Award 2025, Davor Skeledzija and Marcello Grussu, recognising their contributions to diabetes advocacy. The event concluded with a networking dinner, where IDF Europe presented its Exceptional Partnership Award to Maurizio Guidi, from Eli Lilly, and celebrated the 100th anniversary of the Portuguese Diabetes Association (APDP), with a commemorative award received by Prof. Boavida. On March 29, we met again with our member associations for our annual Regional Council where we reviewed our 2025 activities and outlined our priorities for 2026. The meeting also provided a platform for member associations to present their national initiatives, exchange ideas and explore opportunities for collaboration to strengthen the impact of the IDF Europe network. ![]() IDF Europe Symposium at ATTD 2026 During this year’s ATTD 2026, we hosted a symposium on how innovation and early intervention can improve outcomes for people living with, or at risk of, diabetes. The event focused on three key areas: early-stage type 1 diabetes (T1D) detection and monitoring, including the role of language and communication; protecting heart health through effective diabetes prevention and management; and the use of CGMs in preventing and managing diabetes and obesity. We extend our sincere thanks to our moderator, Jaivir Pall, and to all those who joined the symposium, and especially to our speakers, Dr Sufyan Hussain, Marissa Town, Prof. Tsvetalina Tankova and Dr. Sanja Klobučar, for their insightful and engaging presentations. ![]() New publication on T1D screening During our ATTD symposium, IDF Europe Board Member, Dr. Sufyan Hussain, officially launched a new publication: “An international consensus on screening and monitoring early-stage type 1 diabetes: a roadmap to European implementation”. Supported and facilitated by IDF Europe, the paper summarises the latest evidence on early T1D screening and provides policy recommendations to guide decision-makers across Europe in implementing effective screening programmes. IDF Europe Expert Day report: Last December, we convened an Expert Day bringing together people living with diabetes (PwD), healthcare professionals (HCPs), researchers and policymakers to explore the latest advances in diabetes prevention and care. Discussions highlighted key innovations, from T2D remission to progress towards a functional cure for T1D, and how these advances can improve health outcomes across Europe. The event report captures the key evidence and insights from the event, alongside policy actions needed to bridge the gap between scientific progress and We extend a heartfelt thank you to all contributors and participants, as well as partner organisations including the European Liver Patients’ Association, the European Society of Cardiology and the European Kidney Health Alliance.
Save the date: IDF Europe Symposium at EASD The IDF Europe Symposium, held during the EASD 62nd Annual Meeting, will take place on Thursday, 1 October, from 11:00 to 12:30 in Milan, and will be followed by a networking lunch. More information about the Symposium will be available soon. Stay tuned! ![]() MEMBER NEWS
The diabetes community loses an esteemed member in Lyudmila Ivanivna Petrenko It is with great sadness that we share the news of the passing of Lyudmila Ivanivna Petrenko, President of the International Diabetes Association of Ukraine, whose dedication and leadership made a lasting impact on the diabetes community. Her tireless energy and unwavering commitment transformed diabetes care in Ukraine and saved countless lives. Our deepest condolences go to her family, colleagues and loved ones. Her dedication and achievements will continue to inspire the diabetes community for many years to come. ![]() YOUTH PLATFORMApplications for the IDF Europe YLL 2026 are now closed The applications for the IDF Europe Youth Leadership Lab (YLL) 2026 are now closed. We wish to thank everyone who applied as well as our Member Associations and all those who shared news about the YLL with their networks. We received many excellent applications and we will inform the selected participants of the results over the next few weeks. ![]() We look forward to meeting our successful applicants soon! HEALTH RELATED NEWSEPF | Recommendations for the trilogue negotiations on the Critical Medicines Act As trilogue negotiations on the Critical Medicines Act (CMA) are ongoing at EU level, the European Patients’ Forum (EPF) has published a set of recommendations, including the meaningful involvement of people with lived experience throughout CMA implementation and effective EU joint procurement systems to improve the availability, affordability and accessibility of medicines across the EU. Read more Member States’ initiative to reinstate operating grants for health NGOs under EU4Health Backed by several EU Member States, France launched an initiative to reinstate operating grants for non-governmental organisations under the EU4Health Programme from 2026 onwards. Operating grants and sustainable funding are essential to ensure civil society organisations can continue bringing the voices and lived experiences of people, including those living with diabetes, into EU health policymaking. Read more Nature Health, op-ed by Hans Kluge | “A healthy population is a strategic advantage” In a new op-ed published in Nature Health, WHO Europe Regional Director, Dr. Hans Kluge, argues that health is a strategic investment underpinning security, economic growth and demographic resilience. He highlights that chronic conditions such as diabetes, cardiovascular diseases and cancers drive premature death and lost productivity in Europe. With ageing populations and rising pressures, he stresses that investing in prevention, primary care and healthier living is essential to sustain economies and ensure resilient societies. Read more EMA | Insulin supply update The European Medicines Agency (EMA) has issued a notice regarding the discontinuation of certain Eli Lilly insulin presentations containing human insulin, insulin lispro and insulin glargine in selected countries. The specific products affected and the timelines for their withdrawal differ across EU/EEA countries. All discontinuations are expected to occur before Q2 2027, after which the affected insulin presentations will no longer be available. Read more UNDERSTANDING DIABETES
EU RESEARCH PROJECTSASSESS DHT updates IDF Europe is part of ASSESS DHT, a Horizon 2020 project aiming to boost the adoption of trustworthy and effective Digital Health Technologies (DHT) across Europe. Consortium partners are currently seeking input from various stakeholders. Explore the open call and surveys: ![]() OPEN CALL Application deadline: April 17, 2026, 17:00 CET SURVEY FOR PATIENTS AND CLINICIANS Application deadline: April 22, 2026 SURVEY FOR HTA AND DECISION MAKERS Application deadline: April 22, 2026 DigiCare4You updates IDF Europe is proud to be part of the DigiCare4You Horizon 2020 project, which aims to improve early prevention and management of T2D and hypertension (HTN). Join the DigiCare4You closing event! The DigiCare4You final event will take place on April 29, in Brussels. This high-level gathering will bring together policymakers, public health leaders, PwD and other stakeholders to shape the future of innovative solutions for the prevention and management of T2D and HTN. Participants will gain insights into the project’s key achievements and outcomes and will also be given the opportunity to contribute to the development of a roadmap to support implementation at national level. ![]() There are still a few available spots for participants to join the event. If you’re interested, please send an email to izabell.thunstrom@idf-europe.org for more information. Interview with Christina Pelekanou DigiCare4You recently published an interview with Christina Pelekanou, DigiCare4You implementer from Greece. In the interview, she explains how she supports families, particularly parents living with T2D or intermediate hyperglycaemia, by guiding them in making small, sustainable lifestyle changes at home. She shares how these changes can improve blood glucose, body weight, energy, mood and self-confidence, while also positively influencing children’s health. “By personalising advice and setting realistic goals, we help families overcome daily challenges and create lasting impact,” Participant interview with Stella Vlachou In another interview, Stella Vlachou, a DigiCare4You participant from Greece living with intermediate hyperglycaemia, shares her experiences. She talks about her motivation to join the programme, the surprises and challenges she faced and the positive changes she has experienced. Stella also reflects on her hopes for the future and how the programme has helped her take concrete steps towards better health. READINGS ON DIABETESReadings on Diabetes, presented to IDF Europe by Angelo Argenteri, MD, Maria Stella de Sabata, MA, and Andrea Ascoli Marchetti, MD, is a journey through the major diabetes milestones, one of the oldest and still most widespread diseases, with anecdotes, stories, historical facts and a very rich iconography. Each month, the IDF Europe Newsletter presents a chapter from Readings on Diabetes, which can be downloaded in full here. 13. The Leopard Set during the time of Italy’s unification, “The Leopard” by Giuseppe Tomasi di Lampedusa tells the story of a Sicilian noble family facing a period of major change. As old traditions begin to fade and a new social order emerges, the novel captures this shift through the famous line: “If we want everything to stay as it is, everything must change.” Alongside its historical story, the novel also includes a powerful and often overlooked element: the impact of diabetes. Through two characters, Tomasi di Lampedusa describes the serious complications of the By bringing together literature, history and medicine, this chapter shows how stories from the past can help us better understand the human side of living with diabetes. Are you curious to learn about the long quest to understand diabetes? Explore this fascinating story in Chapter 13 of Readings on Diabetes. ![]() UPCOMING EVENTS ACROSS EUROPEDigiCare4You final event European Association for the Study of Diabetes (EASD) 62nd Annual Meeting IDF Europe Symposium at EASD 2026 ![]() Do you want to know more about IDF Europe’s news and events? Please confirm that you are still happy to hear from us! |


























